Balchem Corporation Company Profile (NASDAQ:BCPC)

About Balchem Corporation (NASDAQ:BCPC)

Balchem Corporation logoBalchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry, providing solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems and cereal systems. The Animal Nutrition & Health segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry. The Industrial Products segment includes the manufacture and sale of methylamines.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Special Foods & Welbeing Products
  • Sub-Industry: Specialty Chemicals
  • Symbol: NASDAQ:BCPC
  • CUSIP: 05766520
  • Web:
  • Market Cap: $2.62982 billion
  • Outstanding Shares: 31,958,000
Average Prices:
  • 50 Day Moving Avg: $78.71
  • 200 Day Moving Avg: $78.60
  • 52 Week Range: $67.71 - $89.50
  • Trailing P/E Ratio: 42.46
  • P/E Growth: 1.38
Sales & Book Value:
  • Annual Revenue: $564.08 million
  • Price / Sales: 4.64
  • Book Value: $17.64 per share
  • Price / Book: 4.65
  • Annual Dividend: $0.38
  • Dividend Yield: 0.5%
  • EBITDA: $135.58 million
  • Net Margins: 10.99%
  • Return on Equity: 14.99%
  • Return on Assets: 8.43%
  • Debt-to-Equity Ratio: 0.44%
  • Current Ratio: 2.38%
  • Quick Ratio: 1.65%
  • Average Volume: 89,895 shs.
  • Beta: 1.12
  • Short Ratio: 11.04

Frequently Asked Questions for Balchem Corporation (NASDAQ:BCPC)

What is Balchem Corporation's stock symbol?

Balchem Corporation trades on the NASDAQ under the ticker symbol "BCPC."

How often does Balchem Corporation pay dividends? What is the dividend yield for Balchem Corporation?

Balchem Corporation announced an annual dividend on Thursday, December 15th. Investors of record on Tuesday, December 27th will be paid a dividend of $0.38 per share on Friday, January 20th. This represents a yield of 0.46%. The ex-dividend date of this dividend is Thursday, December 22nd. This is an increase from Balchem Corporation's previous annual dividend of $0.26. View Balchem Corporation's Dividend History.

How were Balchem Corporation's earnings last quarter?

Balchem Corporation (NASDAQ:BCPC) issued its earnings results on Friday, August, 4th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.63 by $0.01. The firm earned $147.08 million during the quarter. Balchem Corporation had a return on equity of 14.99% and a net margin of 10.99%. View Balchem Corporation's Earnings History.

When will Balchem Corporation make its next earnings announcement?

Balchem Corporation is scheduled to release their next quarterly earnings announcement on Friday, November, 3rd 2017. View Earnings Estimates for Balchem Corporation.

Where is Balchem Corporation's stock going? Where will Balchem Corporation's stock price be in 2017?

1 brokers have issued 12-month price targets for Balchem Corporation's stock. Their forecasts range from $60.00 to $60.00. On average, they anticipate Balchem Corporation's share price to reach $60.00 in the next twelve months. View Analyst Ratings for Balchem Corporation.

Who are some of Balchem Corporation's key competitors?

Who are Balchem Corporation's key executives?

Balchem Corporation's management team includes the folowing people:

  • Theodore L. Harris, Chairman of the Board, President, Chief Executive Officer
  • William A. Backus CPA, Chief Financial Officer, Treasurer
  • John E. Kuehner, Vice President - Operations, Executive Officer
  • David F. Ludwig, Vice President, General Manager- Specialty Products, Executive Officer
  • Francis J. Fitzpatrick CPA, Vice President - Administration
  • John Y. Televantos Ph.D., Lead Independent Director
  • Paul D. Coombs, Independent Director
  • David B. Fischer, Independent Director
  • Edward L. McMillan, Independent Director
  • Matthew D. Wineinger, Independent Director

Who owns Balchem Corporation stock?

Balchem Corporation's stock is owned by many different of institutional and retail investors. Top institutional investors include Bath Savings Trust Co (0.19%) and Eqis Capital Management Inc. (0.02%). Company insiders that own Balchem Corporation stock include Dino A Rossi, Edward Mcmillan, Matthew David Houston and William A Backus. View Institutional Ownership Trends for Balchem Corporation.

Who sold Balchem Corporation stock? Who is selling Balchem Corporation stock?

Balchem Corporation's stock was sold by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. Company insiders that have sold Balchem Corporation stock in the last year include Dino A Rossi, Edward Mcmillan and William A Backus. View Insider Buying and Selling for Balchem Corporation.

Who bought Balchem Corporation stock? Who is buying Balchem Corporation stock?

Balchem Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Bath Savings Trust Co. View Insider Buying and Selling for Balchem Corporation.

How do I buy Balchem Corporation stock?

Shares of Balchem Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Balchem Corporation's stock price today?

One share of Balchem Corporation stock can currently be purchased for approximately $81.95.

MarketBeat Community Rating for Balchem Corporation (NASDAQ BCPC)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  126
MarketBeat's community ratings are surveys of what our community members think about Balchem Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Balchem Corporation (NASDAQ:BCPC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating
Consensus Rating:Sell (Score: 1.00)
Consensus Price Target: $60.00 (26.78% downside)
Consensus Price Target History for Balchem Corporation (NASDAQ:BCPC)
Price Target History for Balchem Corporation (NASDAQ:BCPC)
Analysts' Ratings History for Balchem Corporation (NASDAQ:BCPC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/4/2016Pivotal ResearchDowngradeHold -> Sell$65.00 -> $60.00N/AView Rating Details
3/8/2016SidotiDowngradeBuy -> NeutralN/AView Rating Details
2/2/2016Piper Jaffray CompaniesReiterated RatingBuy$73.00 -> $71.00N/AView Rating Details
(Data available from 10/18/2015 forward)


Earnings History for Balchem Corporation (NASDAQ:BCPC)
Earnings by Quarter for Balchem Corporation (NASDAQ:BCPC)
Earnings History by Quarter for Balchem Corporation (NASDAQ BCPC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017$0.62N/AView Earnings Details
8/4/2017Q2 2017$0.63$0.64$147.08 millionViewN/AView Earnings Details
5/9/2017Q1 2017$0.61$0.59$137.73 millionViewN/AView Earnings Details
2/28/2017Q4 2016$0.65$0.67$140.76 millionViewN/AView Earnings Details
11/4/2016Q3 2016$0.65$0.61$138.51 millionViewN/AView Earnings Details
8/5/2016Q2$0.65$0.66$134.77 million$138.80 millionViewN/AView Earnings Details
5/10/2016Q1$0.62$0.58$150.10 million$135.10 millionViewN/AView Earnings Details
2/29/2016Q4$0.57$0.66$144.70 million$132.70 millionViewListenView Earnings Details
11/3/2015Q315$0.60$0.61$150.53 million$140.10 millionViewN/AView Earnings Details
8/4/2015Q215$0.56$0.62$148.87 million$1.33 billionViewN/AView Earnings Details
5/5/2015Q115$0.59$0.62$147.90 million$144.86 millionViewN/AView Earnings Details
2/24/2015Q414$0.59$0.61$153.00 million$162.60 millionViewN/AView Earnings Details
11/10/2014Q314$0.51$0.49$157.00 million$160.50 millionViewN/AView Earnings Details
8/8/2014Q2 14$0.46$0.53$132.23 millionViewN/AView Earnings Details
2/27/2014$0.36$0.35ViewN/AView Earnings Details
11/5/2013Q212$0.41$0.38$86.75 million$87.59 millionViewN/AView Earnings Details
7/31/2013Q2 2013$0.39$0.38ViewN/AView Earnings Details
8/3/2011$0.31$0.34ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Balchem Corporation (NASDAQ:BCPC)

No earnings estimates for this company have been tracked by


Current Dividend Information for Balchem Corporation (NASDAQ:BCPC)
Most Recent Dividend:1/20/2017
Annual Dividend:$0.38
Dividend Yield:0.46%
Payout Ratio:19.69% (Trailing 12 Months of Earnings)
Dividend Payments by Quarter for Balchem Corporation (NASDAQ:BCPC)

Dividend History by Quarter for Balchem Corporation (NASDAQ BCPC)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Balchem Corporation (NASDAQ:BCPC)
Insider Ownership Percentage: 1.59%
Institutional Ownership Percentage: 84.22%
Insider Trades by Quarter for Balchem Corporation (NASDAQ:BCPC)
Institutional Ownership by Quarter for Balchem Corporation (NASDAQ:BCPC)
Insider Trades by Quarter for Balchem Corporation (NASDAQ:BCPC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/15/2017Edward McmillanDirectorSell2,557$81.09$207,347.13View SEC Filing  
3/13/2017William A BackusCFOSell48,500$83.60$4,054,600.00View SEC Filing  
3/3/2017William A BackusCFOSell14,000$86.88$1,216,320.00View SEC Filing  
1/4/2017Edward McmillanDirectorSell1,550$85.00$131,750.00View SEC Filing  
12/8/2016Dino A. RossiDirectorSell16,762$84.68$1,419,406.16View SEC Filing  
11/16/2016Dino A. RossiDirectorSell16,400$77.85$1,276,740.00View SEC Filing  
10/7/2016Dino A RossiDirectorSell16,400$78.57$1,288,548.00View SEC Filing  
9/20/2016Matthew David HoustonGeneral CounselSell4,000$67.83$271,320.00View SEC Filing  
9/9/2016Dino A RossiDirectorSell16,400$68.26$1,119,464.00View SEC Filing  
9/2/2016Edward McmillanDirectorSell1,500$69.75$104,625.00View SEC Filing  
8/26/2016William A BackusCFOSell12,000$68.64$823,680.00View SEC Filing  
8/10/2016Dino A RossiDirectorSell16,400$65.31$1,071,084.00View SEC Filing  
7/14/2016Dino A RossiDirectorSell16,600$62.31$1,034,346.00View SEC Filing  
6/20/2016Edward McmillanDirectorSell3,076$60.25$185,329.00View SEC Filing  
6/17/2016Dino A RossiDirectorSell32,400$59.35$1,922,940.00View SEC Filing  
5/19/2016Dino A RossiDirectorSell200$58.39$11,678.00View SEC Filing  
5/16/2016Matthew David HoustonGeneral CounselSell5,000$62.51$312,550.00View SEC Filing  
4/20/2016Dino A RossiDirectorSell16,400$63.15$1,035,660.00View SEC Filing  
3/23/2016Dino A RossiDirectorSell16,400$59.68$978,752.00View SEC Filing  
9/16/2015Dino A. RossiChairmanSell14,600$58.81$858,626.00View SEC Filing  
8/14/2015Dino A RossiChairmanSell14,600$60.58$884,468.00View SEC Filing  
7/15/2015Dino A RossiChairmanSell7,300$55.58$405,734.00View SEC Filing  
7/14/2015Dino A RossiChairmanSell7,300$55.04$401,792.00View SEC Filing  
7/13/2015David F LudwigVPSell15,000$55.05$825,750.00View SEC Filing  
6/12/2015Frank FitzpatrickVPSell14,935$61.20$914,022.00View SEC Filing  
6/11/2015Dino A RossiCEOSell14,600$60.45$882,570.00View SEC Filing  
6/10/2015David F LudwigVPSell15,000$59.66$894,900.00View SEC Filing  
5/15/2015Frank FitzpatrickVPSell14,000$57.10$799,400.00View SEC Filing  
5/12/2015David F LudwigVPSell15,000$56.51$847,650.00View SEC Filing  
5/8/2015Dino A RossiChairmanSell14,600$57.72$842,712.00View SEC Filing  
5/7/2015David F LudwigVPSell28,500$58.14$1,656,990.00View SEC Filing  
4/16/2015David F LudwigVPSell1,500$58.26$87,390.00View SEC Filing  
4/15/2015Frank FitzpatrickVPSell14,000$55.43$776,020.00View SEC Filing  
4/7/2015Dino A RossiCEOSell14,600$55.90$816,140.00View SEC Filing  
3/16/2015Frank FitzpatrickVPSell14,000$56.07$784,980.00View SEC Filing  
3/4/2015Dino A RossiCEOSell14,600$58.11$848,406.00View SEC Filing  
2/18/2015David F LudwigVPSell15,000$58.16$872,400.00View SEC Filing  
2/17/2015Frank FitzpatrickVPSell14,000$57.85$809,900.00View SEC Filing  
2/5/2015Dino A RossiCEOSell14,600$54.34$793,364.00View SEC Filing  
1/15/2015Frank FitzpatrickVPSell14,000$60.59$848,260.00View SEC Filing  
1/12/2015David F LudwigVPSell15,000$61.43$921,450.00View SEC Filing  
1/8/2015Dino A RossiCEOSell24,200$61.19$1,480,798.00View SEC Filing  
12/15/2014Frank FitzpatrickVPSell14,000$63.01$882,140.00View SEC Filing  
12/10/2014David F LudwigVPSell15,000$63.34$950,100.00View SEC Filing  
12/4/2014Dino A RossiCEOSell24,400$64.92$1,584,048.00View SEC Filing  
11/21/2014Dino A RossiCEOSell24,400$63.97$1,560,868.00View SEC Filing  
11/17/2014Frank FitzpatrickVPSell14,000$64.62$904,680.00View SEC Filing  
10/7/2014Dino A RossiCEOSell24,400$54.56$1,331,264.00View SEC Filing  
9/15/2014Frank FitzpatrickVPSell14,000$54.82$767,480.00View SEC Filing  
9/12/2014Dino A RossiCEOSell36,400$54.95$2,000,180.00View SEC Filing  
8/12/2014Dino A RossiCEOSell19,800$53.25$1,054,350.00View SEC Filing  
7/15/2014Frank FitzpatrickVPSell14,000$49.68$695,520.00View SEC Filing  
7/9/2014Dino A RossiCEOSell17,000$53.48$909,160.00View SEC Filing  
7/8/2014Dino A RossiCEOSell12,200$53.42$651,724.00View SEC Filing  
6/20/2014Dino A RossiCEOSell24,400$53.38$1,302,472.00View SEC Filing  
6/16/2014Frank FitzpatrickCFOSell14,000$53.43$748,020.00View SEC Filing  
5/15/2014Frank FitzpatrickCFOSell14,000$52.44$734,160.00View SEC Filing  
4/15/2014Frank FitzpatrickCFOSell21,003$62.00$1,302,186.00View SEC Filing  
3/17/2014Frank FitzpatrickCFOSell14,000$55.24$773,360.00View SEC Filing  
2/21/2014Dino A RossiCEOSell15,000$50.10$751,500.00View SEC Filing  
2/18/2014Frank FitzpatrickCFOSell14,000$51.48$720,720.00View SEC Filing  
2/10/2014David F LudwigVPSell13,500$50.74$684,990.00View SEC Filing  
1/23/2014Dino A RossiCEOSell15,000$56.82$852,300.00View SEC Filing  
1/15/2014Frank FitzpatrickCFOBuy14,000$11.87$166,180.00View SEC Filing  
1/10/2014David F LudwigVPSell13,500$56.05$756,675.00View SEC Filing  
12/24/2013Dino A RossiCEOSell15,000$57.80$867,000.00View SEC Filing  
12/18/2013Elaine R WedralDirectorSell8,243$57.13$470,922.59View SEC Filing  
12/16/2013Edward McmillanDirectorSell8,000$58.40$467,200.00View SEC Filing  
12/13/2013John Y TelevantosDirectorSell2,000$57.23$114,460.00View SEC Filing  
12/10/2013David F LudwigVPSell13,500$57.39$774,765.00View SEC Filing  
12/2/2013Frank FitzpatrickCFOSell13,500$57.38$774,630.00View SEC Filing  
10/18/2013Dino A RossiCEOSell15,000$57.38$860,700.00View SEC Filing  
10/10/2013David F LudwigVPSell13,500$52.76$712,260.00View SEC Filing  
9/20/2013Dino A RossiCEOSell15,000$50.43$756,450.00View SEC Filing  
9/19/2013John Y TelevantosDirectorSell4,000$49.60$198,400.00View SEC Filing  
9/18/2013Edward McmillanDirectorSell33,488$49.79$1,667,367.52View SEC Filing  
9/10/2013David F LudwigVPSell13,500$49.38$666,630.00View SEC Filing  
9/4/2013Frank FitzpatrickCFOSell13,500$47.77$644,895.00View SEC Filing  
8/20/2013Dino A RossiCEOSell15,000$50.18$752,700.00View SEC Filing  
8/8/2013David F LudwigVPSell24,538$52.54$1,289,226.52View SEC Filing  
8/7/2013John Y TelevantosDirectorSell5,000$52.79$263,950.00View SEC Filing  
8/1/2013Frank FitzpatrickCFOSell22,198$34.28$760,947.44View SEC Filing  
7/19/2013Dino A RossiCEOSell15,000$47.04$705,600.00View SEC Filing  
7/1/2013Frank FitzpatrickCFOSell13,500$45.21$610,335.00View SEC Filing  
6/20/2013Dino A RossiCEOSell15,000$45.49$682,350.00View SEC Filing  
6/18/2013Elaine R WedralDirectorSell4,488$46.00$206,448.00View SEC Filing  
6/13/2013Elaine R WedralDirectorSell4,000$45.96$183,840.00View SEC Filing  
6/6/2013Dana E PutnamInsiderSell36,645$47.25$1,731,476.25View SEC Filing  
6/3/2013Frank FitzpatrickCFOSell13,500$47.90$646,650.00View SEC Filing  
5/10/2013Matthew David HoustonGeneral CounselSell41,229$43.16$1,779,443.64View SEC Filing  
11/8/2012Paul D CoombsDirectorBuy6,000$32.41$194,460.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Balchem Corporation (NASDAQ:BCPC)
Latest Headlines for Balchem Corporation (NASDAQ:BCPC)
DateHeadline logoBalchem selects Diversey's Coelho as new CFO - October 13 at 10:10 PM logoBalchem Corporation Announces Chief Financial Officer Transition - October 12 at 5:17 PM logoETFs with exposure to Balchem Corp. : October 10, 2017 - October 10 at 5:44 PM logoWill Balchem Corporation (BCPC) Continue To Underperform Its Industry? - October 3 at 4:13 PM logoETFs with exposure to Balchem Corp. : September 26, 2017 - October 2 at 4:21 PM logoBCPC Crosses Above Key Moving Average Level - September 27 at 7:40 PM logoBalchem Corporation (BCPC) Short Interest Update - September 16 at 1:44 AM logoETFs with exposure to Balchem Corp. : September 12, 2017 - September 12 at 3:08 AM logoBalchem Corp. :BCPC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 8, 2017 - September 8 at 9:53 PM logoEdited Transcript of BCPC earnings conference call or presentation 4-Aug-17 3:00pm GMT - August 13 at 2:16 AM logoSee what the IHS Markit Score report has to say about Balchem Corp. - August 10 at 2:43 AM logoBalchem Corporation's Business Is Getting Healthier in 2017 - August 5 at 4:04 PM logoBalchem Corporation's Business Is Getting Healthier in 2017 - August 5 at 10:35 AM logoBalchem's (BCPC) CEO Ted Harris on Q2 2017 Results - Earnings Call Transcript - August 4 at 9:48 PM logoBalchem Corporation Reports Record Second Quarter Sales of $147.1 Million with Second Quarter Net Earnings of $16.5 Million and Adjusted Net Earnings of $20.5 Million - August 4 at 4:47 PM logoBalchem Corporation Reports Record Second Quarter Sales of $147.1 Million with Second Quarter Net Earnings of $16.5 Million and Adjusted Net Earnings of $20.5 Million - August 4 at 4:47 PM logoInvestor Network: Balchem Corporation to Host Earnings Call - August 4 at 4:47 PM logoInvestor Network: Balchem Corporation to Host Earnings Call - August 4 at 4:47 PM logoBlachem posts 2Q profit - August 4 at 4:47 PM logoBalchem Corporation (BCPC) Posts Earnings Results - August 4 at 4:20 PM logoBalchem Corp. – Value Analysis (NASDAQ:BCPC) : August 1, 2017 - August 1 at 11:05 PM logoBalchem Corporation (BCPC) Scheduled to Post Quarterly Earnings on Thursday - July 27 at 7:18 AM logoBalchem Corporation Announces Quarterly Conference Call for Second Quarter ... - July 27 at 3:04 AM logoBalchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on August 4, 2017 - July 25 at 9:39 PM logoBalchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on August 4, 2017 - July 25 at 5:16 PM logoBalchem Corp. breached its 50 day moving average in a Bearish Manner : BCPC-US : July 19, 2017 - July 19 at 5:38 PM logoETFs with exposure to Balchem Corp. : July 4, 2017 - July 4 at 8:12 PM logoBalchem Corporation (US: BCPC) to Ring The Nasdaq Stock Market Closing Bell - June 13 at 1:06 PM logoHealth Products Drive Balchem Corporation's Growth - March 1 at 4:13 PM logoBALCHEM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - March 1 at 3:48 PM logoBalchem's (BCPC) CEO Ted Harris on Q4 2016 Results - Earnings Call Transcript - March 1 at 7:49 AM logoBalchem Corporation Reports Fourth Quarter Net Earnings of $15.9 Million with Record Fourth Quarter Adjusted EBITDA of $37.7 Million - February 28 at 12:29 PM logoQ4 2016 Balchem Corp Earnings Release - Before Market Open - February 28 at 12:29 PM logoBALCHEM CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statement - February 22 at 8:53 PM logoBalchem Corporation Announces Quarterly Conference Call for Fourth Quarter ... - February 18 at 9:55 AM logo3 Stocks That Turned $10,000 Into at Least $3.68 Million - February 13 at 4:24 PM logoBalchem: Expect Average Growth Moving Forward - February 9 at 4:03 PM logo[$$] LBO Focus: Private Equity Whets Appetite for Ingredients Deals - February 1 at 4:01 PM logoBALCHEM CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - December 15 at 3:44 PM logoBalchem declares $0.38 dividend - December 15 at 11:48 AM logoBalchem Corporation Sees Steady Health and Nutrition Growth - November 8 at 10:24 AM logoBalchem's (BCPC) CEO Ted Harris on Q3 2016 Results - Earnings Call Transcript - November 5 at 11:44 AM logoBalchem Corporation Announces Quarterly Conference Call for Third - October 28 at 3:30 PM logoBALCHEM CORP Files SEC form 8-K, Change in Directors or Principal Officers - September 20 at 5:55 PM



Balchem Corporation (BCPC) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.